⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ATRA News
Atara Biotherapeutics, Inc
ATRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Atara Biotherapeutics, Inc. to Contact the Firm Today!
accessnewswire.com
ATRA
Class Action Lawsuit Now Underway by Pomerantz LLP Against Atara Biotherapeutics, Inc. – ATRA
accessnewswire.com
ATRA
ATARA DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Atara Biotherapeutics, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ATRA
accessnewswire.com
ATRA
Pomerantz Law Firm Announces the Filing of a Class Action Against Atara Biotherapeutics, Inc. and Certain Officers – ATRA
globenewswire.com
ATRA
Form 8-K
sec.gov
ATRA
Atara Biotherapeutics Announces First Quarter 2026 Financial Results and Operational Progress
businesswire.com
ATRA
Deadline Alert: Atara Biotherapeutics, Inc. (ATRA) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
globenewswire.com
ATRA
Portnoy Law Firm Announces Class Action on Behalf of Atara Biotherapeutics, Inc. Investors
globenewswire.com
ATRA
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 22, 2026 in Atara Biotherapeutics, Inc. Lawsuit - ATRA
prnewswire.com
ATRA
ATRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Atara Biotherapeutics, Inc. to Contact the Firm Today!
accessnewswire.com
ATRA